PTPN11 and cancer: We also demonstrate that SHP2 inhibition can lead to induction of maturation and antigen-presenting programmes in macrophages independent of cancer-cell intrinsic signalling which coincide with recent studies that have characterised the effects of SHP2 inhibition in macrophages which can lead to anti-tumour immune responses.